Production

By taking a One Ceva approach, manufacturing relies on many disciplines to ensure the quality and effectiveness of our vaccines. Our Industrial, Supply Chain and Quality Assurance teams work to provide high quality, innovative, and affordable vaccines across the world.

Furthermore, Ceva employees are dedicated to continuous improvement by embracing new technologies and processes. This allows us to deliver innovative products for the evolving and expanding vaccine needs of poultry, ruminant and swine producers.

Our teams can produce up to 100 billion doses of vaccine per year.

We produce over 60 types of vaccine materials and nearly 50 different vaccines using state‑of‑the‑art technologies. Raw materials are produced using egg-based and tissue-culture methods, aerobic and anaerobic fermentation, as well as bioreactors.

Our portfolio places a special focus on poultry vaccines. In addition to protecting birds against Marek’s disease and Newcastle disease, our products help prevent several other diseases that can cause severe health, environmental and economic impacts. We are one of the world’s largest producers of Marek's-based vaccines.

Beyond poultry, we also manufacture vaccines for swine and ruminants. For these three major species combined, our teams can produce up to 100 billion doses of vaccine per year.

CEVA scientist smiling while working in a lab

Ceva Wildlife Research Fund

Ceva Wildlife Research Fund, empowering science to protect vulnerable animals.

Learn more..